DHA Program Ron Nagel DDS MPH Alaska Native Tribal Health Consortium .
A Phase III study (EMBRACE*) of eribulin mesylate vs. treatment of physician’s choice in patients with locally recurrent or metastatic breast cancer previously.
Florida Oral Health Conference August 2012 Ron Nagel DDS MPH CAPT USPHS (ret)
DHA Program
Florida Oral Health Conference
